Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_assertion type Assertion NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_head.
- NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_assertion wasGeneratedBy ECO_0000203 NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_provenance.
- NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_assertion wasDerivedFrom befree-20140225 NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_provenance.
- NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_assertion SIO_000772 19920204 NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_provenance.
- NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_assertion evidence source_evidence_literature NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_provenance.
- NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_provenance.